Health System and Patient Factors Facilitating the Implementation of Isoniazid Preventive Therapy for People living with HIV attending Care and Treatment Centres in Songea Municipality, Tanzania
Abstract
References
References
Akolo, C., I. Adetifa, S. Shepperd & J. Volmink. (2010). Treatment of Latent Tuberculosis
Infection in HIV Infected Persons. Cochrane Database of Systematic Reviews, Issue 1. Art. No.:
CD000171.
Ayele, A.A., S. A. Atnafie, D..D Balcha, A.T. Weredekal, B.A. Woldegiorgis, … & M.M.
Wotte. (2017). Self-Reported Adherence and Associated Factors to Isoniazid Preventive
Therapy for Latent Tuberculosis Among People Living With HIV/AIDS At Health
Centers in Gondar Town, North West Ethiopia.Patient Prefer Adherence, 11:743–9.
Berhe. M., M. Demissie, G. Tesfaye, M. Berhe, M. Demissie & G. Tesfaye. (2014).
Isoniazid Preventive Therapy Adherence and Associated Factors Among HIV Positive
Patients in Addis Ababa, Ethiopia. Advances in Epidemioly, 2014:1–6.
Conrad, K. B., L. Mteic, D. R. Brooksd, R. Waddelle, M. Bakaric, M. Mateec, … & CRH.
(2014). Increased Mortality Associated With Treated Active Tuberculosis in HIVInfected Adults in Tanzania. NIH Public Access, 4(93):461–466.
Fusch, P. I. & Ness, L. R. (2015). Are We There Yet? Data Saturation in Qualitative Research.
(9), 1408–1416.
Ibrahim, M. (2012). Thematic Analysis : A Critical Review of Its Process and Evaluation. 1(1), 39–47.
Mesele Mindachew, Amare Deribew, Peter Memiah, S. B. (2014). Perceived Barriers to the
Implementation of Isoniazid Preventive Therapy for People Living With Hiv in Resource
Constrained Settings: A Qualitative Study. 8688, 1–6. https://doi.org/ 10.11604/ pamj.
17.26.2641.
Tanzania Commission for AIDS and Zanzibar AIDS Commission. (2018). Tanzania HIV
Impact Survey, (This) 2016-2017: Final Report. Dar es Salaam, Tanzania.
Getahun, H., R. Granich, D. Sculier, C. Gunneberg, L. Blanc, … & P. Nunn. (2010).
Implementation of Isoniazid Preventive Therapy for People Living With HIV
Worldwide : Barriers and Solutions. AIDS, 24 (Suppl. 5):S57–S65.
Golub, J., V. Saraceni, C. Solange, P. Antonio, L. Moulton, … & B. King. (2007). The
Impact of Antiretroviral Therapy and Isoniazid Preventive Therapy on Tuberculosis
Incidence in Hiv-Infected Patients in Rio De Janeiro, Brazil. AIDS,21(11):1441–8.
Habakkuk, A. Y., C. & F.N. Kuaban. (2011). Who Recommended Collaborative Tb/Hiv
Activities: Evaluation of Implementation and Performance in a Rural District Hospital
in Cameroon. Panafrican Medical Journal, 8688:4–9.
Lester, R., R. Hamilton, S. Charalambous, T. Dwadwa, C. Chandler, … & G. J.
Churchyard. (2010). Barriers to Implementation of Isoniazid Preventive Therapy in HIV
Clinics: A Qualitative Study. AIDS, 24 (Suppl. 5):S45–S48.
Makanjuola, T., H.B. Taddese & A Booth. (2014). Factors Associated with Adherence to
Treatment with Isoniazid for the Prevention of Tuberculosis Amongst People Living
with HIV/AIDS: A Systematic Review of Qualitative Data. PLoS ONE. 9(2): e87166.
doi:10.1371/journal.pone.0087166.
Makoni, A., M. Chemhuru, M. Tshimanga, N.T. Gombe, M. Mungati & D. Bangure.
(2015). Evaluation of the Isoniazid Preventive Therapy (IPT) Program in Shurugwi
District, Midlands Province, Zimbabwe, January 2013 to August 2014. Bio Med Central
Research Notes, 8:476.
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Tanzania Journal of Development Studies
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.